Physician

Michael Thomas Latzka, MD

According to 2025 Medicare claims, Michael Latzka, MD (NPI: 1538127543) practices family practice in the Spartanburg, SC market, with the plurality of this provider's patient population coming from Spartanburg, SC. This provider's primary affiliated billing organization is WESTGATE FAMILY PHYSICIANS PA (NPI: 1174577258; TIN: 57-0677536) and primary practice location at 29301-1531. Latzka is affiliated with the Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Latzka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 563 traditional Medicare patients, billed 11,389 HCPCS/CPT codes, and received $314,376 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 16,388 prescription claims across 853 beneficiaries totaling $1,143,650 in drug costs, led by Eliquis (Apixaban). DME data shows 409 claims. Open Payments data shows 45 records totaling $857. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $168,387 to $314,376. Similarly, Part D prescription costs have risen steadily, from $712,122 to $1,143,650. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	461	12,915	$168,387
2016	462	11,873	$173,385
2017	471	9,747	$174,563
2018	436	8,039	$187,320
2019	578	10,081	$256,324
2020	602	9,462	$232,412
2021	605	9,680	$261,122
2022	611	9,926	$254,203
2023	581	10,321	$290,294
2024	563	11,389	$314,376

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	690	14,643	$712,122
2016	666	14,475	$740,971
2017	695	14,163	$717,233
2018	687	14,608	$754,145
2019	775	15,872	$892,170
2020	845	16,727	$969,969
2021	825	15,783	$924,682
2022	855	15,994	$978,606
2023	816	16,229	$1,177,440
2024	853	16,388	$1,143,650

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	134	508	$21,293
2016	79	496	$15,871
2017	116	434	$11,252
2018	85	445	$11,133
2019	132	369	$8,206
2020	72	255	$6,289
2021	73	338	$12,490
2022	101	381	$15,074
2023	124	379	$16,556
2024	134	409	$19,692

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	301	301	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	457	895	$76
36415	Insertion of needle into vein for collection of blood sample	439	846	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	302	490	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	331	484	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	198	7,839	$150,877
Farxiga	Dapagliflozin Propanediol	138	6,244	$113,567
Xarelto	Rivaroxaban	93	3,970	$71,995
Ozempic	Semaglutide	54	2,048	$57,340
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	88	3,804	$55,717

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	20	$9,101
A7031	Face mask interface, replacement for full face mask, each	N	13	34	$2,605
A7030	Full face mask used with positive airway pressure device, each	N	14	31	$2,186
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	70	$2,001
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	21	$1,006

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$857	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Thomas Latzka, MD?

Tedicare shows public-source Medicare data for Michael Thomas Latzka, MD (NPI 1538127543), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Thomas Latzka, MD have ACO affiliation data?

Michael Thomas Latzka, MD is shown with ACO affiliation data for Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to Michael Thomas Latzka, MD?

Michael Thomas Latzka, MD is linked to WESTGATE FAMILY PHYSICIANS PA (billing NPI 1174577258) in the available physician profile data.

Does Michael Thomas Latzka, MD have Open Payments data?

Michael Thomas Latzka, MD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.